Articles by Disease (Hematological Malignancies)

Netrin and DCC: Axon Guidance Regulators at the Intersection of Nervous System Development and Cancer

Journal: Current Drug Targets
Volume: 10
Page: 602-610
Author(s): M. Duman-Scheel

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16
Page: 2212-2234
Author(s): Tadeusz Robak

Antibodies as Crypts of Antiinfective and Antitumor Peptides

Journal: Current Medicinal Chemistry
Volume: 16
Page: 2305-2323
Author(s): W. Magliani, S. Conti, R. L.O.R. Cunha, L. R. Travassos and L. Polonelli

The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9
Page: 526-542
Author(s): Andrew J. Wiemer, Raymond J. Hohl and David F. Wiemer

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9
Page: 550-559
Author(s): Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

Journal: Current Medicinal Chemistry
Volume: 16
Page: 2075-2085
Author(s): Tamer E. Fandy

Detection of Clonal Immunoglobulin and T-Cell Receptor Gene Recombination in Hematological Malignancies: Monitoring Minimal Residual Disease

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9
Page: 124-135
Author(s): Herbert Garcia-Castillo and Patricio Barros-Nunez